Stephen D. Ryder

Twenty-eight day safety, antiviral activity, and pharmacokinetics of tenofovir alafenamide for treatment of chronic hepatitis B infection.

John F. Flaherty, G. Foster, K. Agarwal, 2015, Journal of hepatology.

HCV treatment rates and sustained viral response among people who inject drugs in seven UK sites: real world results and modelling of treatment impact

D. De Angelis, D. Angelis, P. Vickerman, 2014, Journal of viral hepatitis.